Table of Contents
Paclitaxel In PAD
Applying What We've Learned Since the Meta-Analysis
In This Issue
Guest Chief Medical Editors' Page
Nine Months Later… An Interview With Konstantinos Katsanos, MD
Dr. Katsanos's thoughts regarding the vascular community's reaction to his group's meta-analysis, the potential influence of follow-up and adjudication variables, non-SFA applications, and what comes next.
With Konstantinos Katsanos, MSc, MD, PhD, EBIR
Paclitaxel Post-Panel: FDA Discusses What's Next From a Regulatory Perspective
An interview with representatives from the FDA Center for Devices and Radiological Health on the key updates to the letter to health care providers, lessons learned for future trials and follow-up protocols, and additional plans for monitoring in the future.
With Eleni Whatley, PhD, and Andrew Farb, MD
Real-World Data Collection Regarding Paclitaxel Treatment
An overview of why real-world data are pertinent to the safety assessment of paclitaxel-coated devices, with separate summaries of the projects investigating the late mortality signal via real-world data analyses.
By Anna Krawisz, MD, and Eric A. Secemsky, MD
Sponsored by Ra Medical Systems, Inc.
European Featured Technology
Medical Affairs Corner
September 2019 Supplement